Results 141 to 150 of about 1,696 (185)

From critical care to organ preservation: the potential role of hemadsorption in transplantation-a narrative review. [PDF]

Hepatobiliary Surg Nutr
Jiao C, Sun K, Shamugarajah K, Zhang M, Wehrle CJ, Panconesi R, Satish S, Karakaya O, Fairchild RL, Hashimoto K, Miller C, Perez-Protto S, Schlegel A.   +12 more
europepmc   +1 more source

Hemoadsorption in the Management of Septic Shock: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Steindl D, Schroeder T, Krannich A, Nee J.   +3 more
europepmc   +1 more source

Effective management of pediatric septic shock: a case study utilizing continuous renal replacement therapy with cytosorb and citrate in a leukemic patient with hyper-interleukin (IL)-6-naemia and severe thrombocytopenia. [PDF]

BMC Infect Dis
Saeed A, Jafarian H, Amanati A.
europepmc   +1 more source

Fatal outcome of severe serotonin syndrome and acute respiratory distress syndrome after self-poisoning with paroxetine: a case report. [PDF]

J Med Case Rep
Pütz SM, Hüser C, Onur OA, Steindl D, Eichenauer DA, Naendrup JH, Neumann MA, Schmidt NM, Stein AFV, Böll B.   +9 more
europepmc   +1 more source

CytoSorb^® Hemadsorption in Cardiogenic Shock: A Real-World Analysis of Hemodynamics, Organ Function, and Clinical Outcomes During Mechanical Circulatory Support. [PDF]

Biomedicines
Kreutz J, Harbaum L, Barutcu CB, Rehman AS, Patsalis N, Mihali K, Chatzis G, Choukeir M, Syntila S, Schieffer B, Markus B.   +10 more
europepmc   +1 more source

Dual Blood Purification with CytoSorb and oXiris in Managing Recurrent Septic Shock: A Case Report. [PDF]

Am J Case Rep
Włochacz B, Rybak A, Próchnicka A, Rustecki B, Wendt D, Klimkiewicz J.   +5 more
europepmc   +1 more source

Current Knowledge on the Impact of Extracorporeal Blood Purification Devices on Drug Clearance - Systematic Search & Narrative Review.

Blood Purif
Paul R, Ansari AS, Ballesteros D, Klaus T, Honoré PM.   +4 more
europepmc   +1 more source

Impact of CytoSorb on kinetics of vancomycin and bivalirudin in critically ill patients

Artificial Organs, 2021
AbstractCytoSorb is a promising tool to treat severe inflammatory status with multiple mechanisms in the acute care setting. Its effect on drugs is, however, poorly documented in vivo, although removal of small molecules might translate into decreased blood levels of life‐saving medications. The aim of this study was to assess the impact of CytoSorb on
Anna Mara Scandroglio, Pasquale Nardelli, Evgeny Fominskiy   +2 more
exaly   +4 more sources

Initial experience with CytoSorb therapy in patients receiving left ventricular assist devices

Artificial Organs, 2022
BACKGROUND: The use of left ventricular assist devices (LVAD) in patients with advance heart failure is still associated with an important risk of immune dysregulation and infections.
Konstantin Zhigalov, Jef Van Den Eynde, Alina Zubarevich   +2 more
exaly   +2 more sources